Detalhe da pesquisa
1.
Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial.
Lancet Oncol
; 17(8): 1047-1060, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27339115
2.
Reproducibility in Radiomics: A Comparison of Feature Extraction Methods and Two Independent Datasets.
Appl Sci (Basel)
; 166(1)2024 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38725869
3.
Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: preliminary safety results from the CHHiP randomised controlled trial.
Lancet Oncol
; 13(1): 43-54, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22169269
4.
Implementing cone-beam computed tomography-guided online adaptive radiotherapy in cervical cancer.
Clin Transl Radiat Oncol
; 40: 100596, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36910024
5.
Absorbed dose ratios for repeated therapy of neuroblastoma with I-131 mIBG.
Cancer Biother Radiopharm
; 18(1): 81-7, 2003 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-12667311
6.
Coplanar intensity-modulated radiotherapy class solution for patients with prostate cancer with bilateral hip prostheses with and without nodal involvement.
Med Dosim
; 38(2): 165-70, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23265938